George Fennell - Feb 7, 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for George Fennell
Stock symbol
IDXX
Transactions as of
Feb 7, 2025
Transactions value $
-$3,724,673
Form type
4
Date filed
2/11/2025, 05:00 PM
Previous filing
Feb 16, 2024
Next filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $99.9K +1.26K +18.15% $79.54 8.18K Feb 7, 2025 Direct
transaction IDXX Common Stock Options Exercise $794K +9.99K +122.14% $79.54 18.2K Feb 10, 2025 Direct
transaction IDXX Common Stock Sale -$4.62M -9.99K -54.98% $462.53 8.18K Feb 10, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise $0 -1.26K -100% $0.00 0 Feb 7, 2025 Common Stock 1.26K $79.54 Direct F2
transaction IDXX Non-Qualified Stock Option (right-to-buy) Options Exercise $0 -9.99K -100% $0.00 0 Feb 10, 2025 Common Stock 9.99K $79.54 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average price of the shares sold ranging from a low of $462.4501 to a high of $462.80 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F2 Grant of option to buy 628 shares of Issuer common stock that vested in one installment on February 14, 2020, without giving effect to a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015 (the 'Stock Split'). The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect the Stock Split.
F3 Grant of option to buy 9,986 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2016, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect the Stock Split.